skip to main content

L.O.S.E Weight

Participants will be randomised to either taking the study drug (subcutaneous liraglutide (max dose 3mg daily)) or a placebo for 6 months.

To take part you must meet the following criteria:

  • Have a diagnosis of schizophrenia, schizo-affective disorder or first episode psychosis.       

  • Aged between 18 – 75 years

  • Treatment with an antipsychotic medication for a minimum of one month

  • Be either obese or overweight with at least one weight related consequence such as hypertension.

  • Ability and willingness to take the study drug (liraglutide) or placebo.

If you would like to take part or want more information please contact the study lead:

Study Contact: Clare Whicher

Email: Clare.Whicher@nhs.net

Tel: 023 8047 5258

Page Comments